Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE697
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,180
Award facts
- Contract value 100% obligated
- $18,179.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,179.77 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. The contract will be completed by January 9, 2026, and represents a non-competitive delivery order under a larger indefinite delivery contract vehicle with the DLA. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, while its parent entity, Cencora, Inc. (doing business as AmerSourceBergen), holds the overarching IDC agreement. The place of performance is established in Conshohocken, PA.
This delivery order falls under AmerSourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. The contract encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. No set-aside designation applies to this award, reflecting the open and competitive procurement framework under which AmerSourceBergen operates as a critical vendor within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FE697?
SPE2DR26FE697 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FE697 worth?
The government has obligated $18,180 on SPE2DR26FE697.
Is contract SPE2DR26FE697 an order under another contract?
Yes. SPE2DR26FE697 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE697 competed?
The extent of competition for SPE2DR26FE697 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award